Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity.
about
Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.Hepatic venous outflow obstruction: three similar syndromes.Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Prophylaxis and treatment controversies.Thromboembolism in cancer patients: pathogenesis and treatment.Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
P2860
Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Anti-thrombin III in the manag ...... lantation-associated toxicity.
@ast
Anti-thrombin III in the manag ...... lantation-associated toxicity.
@en
type
label
Anti-thrombin III in the manag ...... lantation-associated toxicity.
@ast
Anti-thrombin III in the manag ...... lantation-associated toxicity.
@en
prefLabel
Anti-thrombin III in the manag ...... lantation-associated toxicity.
@ast
Anti-thrombin III in the manag ...... lantation-associated toxicity.
@en
P2093
P2860
P356
P1476
Anti-thrombin III in the manag ...... plantation-associated toxicity
@en
P2093
Edward Peres
Esteban M Abella
Jared Klein
Muneer H Abidi
Roger Dansey
P2860
P304
P356
10.1345/APH.1D235
P407
P577
2004-04-27T00:00:00Z